Sermorelin + GHK-Cu Stack: Evidence, Mechanism, and Protocol At a glance Sermorelin class / GHRH 1-29 analog, stimulates pituitary GH release GHK-Cu class / copper-binding tripeptide (Gly-His-Lys-Cu) Primary sermorelin target / pituitary somatotrophs via GHRH receptor Primary GHK-Cu target / fibroblasts, macrophages, endothelial cells Highest-quality sermorelin evidence / placebo-controlled trial by Vittone et al
GHK-Cu typically dissolves within 2-3 minutes of gentle swirling, but some powder may take longer
once-daily dosing for basal coverage Bolus/prandial insulins: Insulin lispro, aspart, glulisine
Infusion therapy is customized based on labs, symptoms, and goals
Peptide therapy should be viewed as part of a comprehensive wellness approach that includes exercise, nutrition, sleep, and healthy lifestyle habits
May cause mild nausea or dizziness in some users